RT @winsoncheung: RWE from our @cancerHSR group indicates that many cancer patients have complex co-morbidities that affect cancer treatmen…
RT @winsoncheung: RWE from our @cancerHSR group indicates that many cancer patients have complex co-morbidities that affect cancer treatmen…
RT @winsoncheung: RWE from our @cancerHSR group indicates that many cancer patients have complex co-morbidities that affect cancer treatmen…
RWE from our @cancerHSR group indicates that many cancer patients have complex co-morbidities that affect cancer treatment and followup. We must focus on cancer but never neglect other aspects of a patient’s health too. @AHS_CancerCare https://t.co/h9NQzEf
【ステージ1-III大腸癌12265例観察:1/3に並存症。最多はCV疾患とDM。平均3.8年観察期間中、がん死以外の最大死因は循環器疾患。CV疾患にDM並存で、診断後の生存期間中央値は3.3年】 J Cancer Surviv https://t.co/uKG6LbxWcO
Good to see increasing attention being paid to impact of #comorbidities on outcomes for ppl with #cancer. https://t.co/RruxpzFiWV #cancersurvivorship #colorectalcancer